Invention Grant
- Patent Title: Gene therapy composition for use in diabetes treatment
-
Application No.: US14951810Application Date: 2015-11-25
-
Publication No.: US11001857B2Publication Date: 2021-05-11
- Inventor: Fátima Bosch Tubert , Eduard Ayuso López , David Callejas Casti{tilde over (η)}eiras
- Applicant: UNIVERSITAT AUTÓNOMA DE BARCELONA
- Applicant Address: ES Barcelona
- Assignee: UNIVERSITAT AUTÓNOMA DE BARCELONA
- Current Assignee: UNIVERSITAT AUTÓNOMA DE BARCELONA
- Current Assignee Address: ES Barcelona
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: ES10169309.1 20100712
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K48/00 ; A61K38/28 ; C07K14/62 ; C12N9/12 ; A61K9/00
Abstract:
New gene therapy constructions and compositions are the subject of present invention. The gene therapy compositions consist in adeno-associated vectors which jointly express insulin (Ins) and glucokinase (Gck) genes. The new gene therapy constructions are useful for treatment of diabetes either in dogs or human beings.
Public/Granted literature
- US20160074534A1 GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT Public/Granted day:2016-03-17
Information query
IPC分类:
